BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2012;:CD004407. [PMID: 22336803 DOI: 10.1002/14651858.CD004407.pub3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 54] [Article Influence: 7.9] [Reference Citation Analysis]
Number Citing Articles
1 Okabayashi H, Komada K, Kidokoro M, Kitamura T, Miyano S, Ito T, Phounphenghak K, Pathammavong C, Murano K, Nagai M, Mori Y, Komase K, Xeuatvongsa A, Takeda M, Hachiya M. Seroprevalence of mumps before the introduction of mumps-containing vaccine in Lao PDR: results from a nationwide cross-sectional population-based survey. BMC Res Notes 2019;12:155. [PMID: 30890154 DOI: 10.1186/s13104-019-4194-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Lindburg M, Ogden MA. Infectious Sialadenitis. Curr Otorhinolaryngol Rep 2021;9:87-91. [DOI: 10.1007/s40136-020-00315-5] [Reference Citation Analysis]
3 Thyagarajan V, Su S, Gee J, Duffy J, McCarthy NL, Chan KA, Weintraub ES, Lin ND. Identification of seizures among adults and children following influenza vaccination using health insurance claims data. Vaccine 2013;31:5997-6002. [PMID: 24148576 DOI: 10.1016/j.vaccine.2013.10.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
4 Takla A, Böhmer MM, Klinc C, Kurz N, Schaffer A, Stich H, Stöcker P, Wichmann O, Koch J. Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011. Hum Vaccin Immunother 2014;10:140-5. [PMID: 24091837 DOI: 10.4161/hv.26642] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
5 Branch-Elliman W, Savor Price C, Bessesen MT, Perl TM. Using the Pillars of Infection Prevention to Build an Effective Program for Reducing the Transmission of Emerging and Reemerging Infections. Curr Environ Health Rep 2015;2:226-35. [PMID: 26231500 DOI: 10.1007/s40572-015-0059-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Bester JC. Measles Vaccination is Best for Children: The Argument for Relying on Herd Immunity Fails. J Bioeth Inq 2017;14:375-84. [PMID: 28815434 DOI: 10.1007/s11673-017-9799-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
7 Swartz J, Aronsson B, Lindblad F, Järnbert-Pettersson H, Scheynius A, Pershagen G, Alm J. Vaccination and Allergic Sensitization in Early Childhood - The ALADDIN Birth Cohort. EClinicalMedicine 2018;4-5:92-8. [PMID: 31193660 DOI: 10.1016/j.eclinm.2018.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Lam E, Rosen JB, Zucker JR. Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity. Clin Microbiol Rev 2020;33:e00151-19. [PMID: 32102901 DOI: 10.1128/CMR.00151-19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
9 Patel C, Beard F, Hendry A, Quinn H, Dey A, Macartney K, Hueston L, Dwyer DE, McIntyre P. Australian mumps serosurvey 2012-2013: any cause for concern? Commun Dis Intell (2018) 2020;44. [PMID: 32829703 DOI: 10.33321/cdi.2020.44.67] [Reference Citation Analysis]
10 Gorun F, Malita D, Ciohat I, Vilibic-Cavlek T, Feier H, Tabain I, Craina M, Cretu O, Navolan D. Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization. Vaccines (Basel) 2021;9:104. [PMID: 33572943 DOI: 10.3390/vaccines9020104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pittet LF, Abbas M, Siegrist CA, Pittet D. Missed vaccinations and critical care admission: all you may wish to know or rediscover-a narrative review. Intensive Care Med 2020;46:202-14. [PMID: 31773179 DOI: 10.1007/s00134-019-05862-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Zamir CS, Schroeder H, Shoob H, Abramson N, Zentner G. Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases. Hum Vaccin Immunother 2015;11:1413-7. [PMID: 25874726 DOI: 10.1080/21645515.2015.1021522] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
13 Carazo S, Billard MN, Boutin A, De Serres G. Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis. BMC Infect Dis 2020;20:251. [PMID: 32223757 DOI: 10.1186/s12879-020-4870-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Newman LP, Njoroge A, Magaret A, Chohan BH, Gitomea VW, Wald A, Gorstein J, Overbaugh J, Wamalwa D, Maleche-Obimbo E, Nduati R, Farquhar C. Sustained Responses to Measles Revaccination at 24 Months in HIV-infected Children on Antiretroviral Therapy in Kenya. Pediatr Infect Dis J 2017;36:1148-55. [PMID: 28198789 DOI: 10.1097/INF.0000000000001572] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Hajj Hussein I, Chams N, Chams S, El Sayegh S, Badran R, Raad M, Gerges-Geagea A, Leone A, Jurjus A. Vaccines Through Centuries: Major Cornerstones of Global Health. Front Public Health 2015;3:269. [PMID: 26636066 DOI: 10.3389/fpubh.2015.00269] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 8.7] [Reference Citation Analysis]
16 Vassantachart JM, Yeo AH, Vassantachart AY, Jacob SE, Golkar L. Art of prevention: The importance of measles recognition and vaccination. Int J Womens Dermatol 2020;6:89-93. [PMID: 32258338 DOI: 10.1016/j.ijwd.2019.06.031] [Reference Citation Analysis]
17 Choe YJ, Jee Y, Oh MD, Lee JK. Measles Elimination Activities in the Western Pacific Region: Experience from the Republic of Korea. J Korean Med Sci 2015;30 Suppl 2:S115-21. [PMID: 26617443 DOI: 10.3346/jkms.2015.30.S2.S115] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
18 Plans-Rubió P. Why does measles persist in Europe? Eur J Clin Microbiol Infect Dis 2017;36:1899-906. [PMID: 28550369 DOI: 10.1007/s10096-017-3011-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
19 Casale M, Di Maio N, Verde V, Scianguetta S, Di Girolamo MG, Tomeo R, Roberti D, Misso S, Perrotta S. Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients. Vaccines (Basel) 2021;9:561. [PMID: 34072263 DOI: 10.3390/vaccines9060561] [Reference Citation Analysis]
20 Benchimol EI, Tse F, Carroll MW, deBruyn JC, McNeil SA, Pham-Huy A, Seow CH, Barrett LL, Bessissow T, Carman N, Melmed GY, Vanderkooi OG, Marshall JK, Jones JL. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines. J Can Assoc Gastroenterol 2021;4:e59-71. [PMID: 34476338 DOI: 10.1093/jcag/gwab015] [Reference Citation Analysis]
21 Sipahi S, Ozceker D, Gokcay G, Guler N, Tamay Z. A Case of Anaphylaxis to Measles Vaccination in an Infant with Cow's Milk Allergy. Pediatr Allergy Immunol Pulmonol 2019;32:135-8. [PMID: 32140284 DOI: 10.1089/ped.2019.0993] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Gori D, Costantino C, Odone A, Ricci B, Ialonardi M, Signorelli C, Vitale F, Fantini MP. The Impact of Mandatory Vaccination Law in Italy on MMR Coverage Rates in Two of the Largest Italian Regions (Emilia-Romagna and Sicily): An Effective Strategy to Contrast Vaccine Hesitancy. Vaccines (Basel) 2020;8:E57. [PMID: 32019092 DOI: 10.3390/vaccines8010057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Plans-Rubió P. Are the Objectives Proposed by the WHO for Routine Measles Vaccination Coverage and Population Measles Immunity Sufficient to Achieve Measles Elimination from Europe? Vaccines (Basel) 2020;8:E218. [PMID: 32414021 DOI: 10.3390/vaccines8020218] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Brownwright TK, Dodson ZM, van Panhuis WG. Spatial clustering of measles vaccination coverage among children in sub-Saharan Africa. BMC Public Health 2017;17:957. [PMID: 29246217 DOI: 10.1186/s12889-017-4961-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
25 Lehmann C, Berner R, Bogner JR, Cornely OA, de With K, Herold S, Kern WV, Lemmen S, Pletz MW, Ruf B, Salzberger B, Stellbrink HJ, Suttorp N, Ullmann AJ, Fätkenheuer G, Jung N. The "Choosing Wisely" initiative in infectious diseases. Infection 2017;45:263-8. [PMID: 28290130 DOI: 10.1007/s15010-017-0997-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
26 Cecinati V, Principi N, Brescia L, Giordano P, Esposito S. Vaccine administration and the development of immune thrombocytopenic purpura in children. Hum Vaccin Immunother 2013;9:1158-62. [PMID: 23324619 DOI: 10.4161/hv.23601] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
27 Nakayama T, Eda M, Hirano M, Goto W. Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial. Hum Vaccin Immunother 2019;15:1139-44. [PMID: 30724658 DOI: 10.1080/21645515.2019.1578591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Francis JR, Richmond P, Robins C, Lindsay K, Levy A, Effler PV, Borland M, Blyth CC. An observational study of febrile seizures: the importance of viral infection and immunization. BMC Pediatr 2016;16:202. [PMID: 27914475 DOI: 10.1186/s12887-016-0740-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
29 Park SH. Resurgence of mumps in Korea. Infect Chemother 2015;47:1-11. [PMID: 25844258 DOI: 10.3947/ic.2015.47.1.1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
30 Kauttonen J, Hannukainen J, Tikka P, Suomala J. Predictive modeling for trustworthiness and other subjective text properties in online nutrition and health communication. PLoS One 2020;15:e0237144. [PMID: 32760095 DOI: 10.1371/journal.pone.0237144] [Reference Citation Analysis]
31 Arapović J, Sulaver Ž, Rajič B, Pilav A. The 2019 measles epidemic in Bosnia and Herzegovina: What is wrong with the mandatory vaccination program? Bosn J Basic Med Sci 2019;19:210-2. [PMID: 31064166 DOI: 10.17305/bjbms.2019.4266] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Shapiro JM. Special Interests and the Media: Theory and an Application to Climate Change. J Public Econ 2016;144:91-108. [PMID: 28725092 DOI: 10.1016/j.jpubeco.2016.10.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 2.7] [Reference Citation Analysis]
33 Seo SH, Jang Y. Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection. Vaccines (Basel) 2020;8:E584. [PMID: 33022950 DOI: 10.3390/vaccines8040584] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
34 Jackson BD, Black RE. Available studies fail to provide strong evidence of increased risk of diarrhea mortality due to measles in the period 4-26 weeks after measles rash onset. BMC Public Health 2017;17:783. [PMID: 29143685 DOI: 10.1186/s12889-017-4745-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
35 Yoo HJ. Recent increase in autism and ADHD: true or inflated? J Korean Med Sci 2013;28:974-5. [PMID: 23853476 DOI: 10.3346/jkms.2013.28.7.974] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
36 Braeye T, Sabbe M, Hutse V, Flipse W, Godderis L, Top G. Obstacles in measles elimination: an in-depth description of a measles outbreak in Ghent, Belgium, spring 2011. Arch Public Health 2013;71:17. [PMID: 23834074 DOI: 10.1186/0778-7367-71-17] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
37 Goddard NV, Waterhouse N. Regenerative Medicine, Stem Cell Therapies, and Platelet-Rich Plasma: Where Is the Evidence? Aesthet Surg J 2020;40:460-5. [PMID: 31930387 DOI: 10.1093/asj/sjz317] [Reference Citation Analysis]
38 Sasaki H, Fukunaga T, Asano A, Suzuki Y, Nakanishi Y, Kondo J, Ishikawa H, Shibata N. A Survey of Vaccine-Induced Measles IgG Antibody Titer to Verify Temporal Changes in Response to Measles Vaccination in Young Adults. Vaccines (Basel) 2019;7:E118. [PMID: 31546797 DOI: 10.3390/vaccines7030118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
39 Zhang L, Wang Z, Hu Y, Deng X, Guo H, Sun X, Tang F, Zhou M, Liu Y. Application of a mixture model to assess the effect of measles-mumps-rubella vaccine on the mumps epidemic in children from kindergarten to early school age in Jiangsu Province, China. Hum Vaccin Immunother 2018;14:2654-9. [PMID: 29792546 DOI: 10.1080/21645515.2018.1480239] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Pellett PE, Mitra S, Holland TC. Basics of virology. Handb Clin Neurol 2014;123:45-66. [PMID: 25015480 DOI: 10.1016/B978-0-444-53488-0.00002-X] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
41 Povey M, Aris E, Cheuvart B, Hall G, Cohet C, Willame C. Effectiveness of "Priorix" Against Measles and Mumps Diseases in Children Born After 2004 in the United Kingdom: A Retrospective Case-control Study Using the Clinical Practice Research Datalink GOLD Database. Pediatr Infect Dis J 2021;40:590-6. [PMID: 33956757 DOI: 10.1097/INF.0000000000003111] [Reference Citation Analysis]
42 Geier DA, Kern JK, Geier MR. Childhood MMR vaccination and the incidence rate of measles infection: a ten year longitudinal cohort study of American children born in the 1990s. BMC Pediatr 2019;19:325. [PMID: 31506095 DOI: 10.1186/s12887-019-1710-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
43 Glasser JW, Feng Z, Omer SB, Smith PJ, Rodewald LE. The effect of heterogeneity in uptake of the measles, mumps, and rubella vaccine on the potential for outbreaks of measles: a modelling study. Lancet Infect Dis 2016;16:599-605. [PMID: 26852723 DOI: 10.1016/S1473-3099(16)00004-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
44 Hambleton S, Goodbourn S, Young DF, Dickinson P, Mohamad SM, Valappil M, McGovern N, Cant AJ, Hackett SJ, Ghazal P, Morgan NV, Randall RE. STAT2 deficiency and susceptibility to viral illness in humans. Proc Natl Acad Sci U S A 2013;110:3053-8. [PMID: 23391734 DOI: 10.1073/pnas.1220098110] [Cited by in Crossref: 141] [Cited by in F6Publishing: 129] [Article Influence: 15.7] [Reference Citation Analysis]
45 Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev 2020;4:CD004407. [PMID: 32309885 DOI: 10.1002/14651858.CD004407.pub4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
46 NNDSS Annual Report Working Group. Australia’s notifiable disease status, 2015: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2019;43. [DOI: 10.33321/cdi.2019.43.6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
47 MMR-162 Study Group. Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study. Hum Vaccin Immunother 2018;14:2921-31. [PMID: 30118386 DOI: 10.1080/21645515.2018.1502527] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
48 Bellavite P. Causality assessment of adverse events following immunization: the problem of multifactorial pathology. F1000Res 2020;9:170. [PMID: 32269767 DOI: 10.12688/f1000research.22600.2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
49 Bartelme RR. Anthroposophic Medicine: A Short Monograph and Narrative Review-Foundations, Essential Characteristics, Scientific Basis, Safety, Effectiveness and Misconceptions. Glob Adv Health Med 2020;9:2164956120973634. [PMID: 33457106 DOI: 10.1177/2164956120973634] [Reference Citation Analysis]
50 Ma C, Liu Y, Tang J, Jia H, Qin W, Su Y, Wang H, Hao L. Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China. Hum Vaccin Immunother 2018;14:1392-7. [PMID: 29377772 DOI: 10.1080/21645515.2018.1428508] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Mulchandani R, Sibal B, Phillips A, Suleman S, Banerjee A, Teagle R, Foulkes S, Spence K, Edeghere O. A large outbreak of measles in the West Midlands, England, 2017-2018: descriptive epidemiology, control measures and lessons learnt. Epidemiol Infect 2021;149:e114. [PMID: 33866992 DOI: 10.1017/S0950268821000868] [Reference Citation Analysis]
52 Abad CL, Safdar N. The Reemergence of Measles. Curr Infect Dis Rep 2015;17:51. [PMID: 26446612 DOI: 10.1007/s11908-015-0506-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
53 Busch E, Kubon KD, Mayer JKM, Pidelaserra-Martí G, Albert J, Hoyler B, Heidbuechel JPW, Stephenson KB, Lichty BD, Osen W, Eichmüller SB, Jäger D, Ungerechts G, Engeland CE. Measles Vaccines Designed for Enhanced CD8+ T Cell Activation. Viruses 2020;12:E242. [PMID: 32098134 DOI: 10.3390/v12020242] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
54 Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev 2021;11:CD004407. [PMID: 34806766 DOI: 10.1002/14651858.CD004407.pub5] [Reference Citation Analysis]
55 Moraes-Fontes MF, Antunes AM, Gruner H, Riso N. Vaccination of Adult Patients with Systemic Lupus Erythematosus in Portugal. Int J Rheumatol 2016;2016:2845617. [PMID: 27069477 DOI: 10.1155/2016/2845617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
56 Wesolowski A, O'Meara WP, Tatem AJ, Ndege S, Eagle N, Buckee CO. Quantifying the impact of accessibility on preventive healthcare in sub-Saharan Africa using mobile phone data. Epidemiology 2015;26:223-8. [PMID: 25643101 DOI: 10.1097/EDE.0000000000000239] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
57 Adhikari BB, Goodson JL, Chu SY, Rota PA, Meltzer MI. Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development. Drugs R D 2016;16:327-38. [PMID: 27696306 DOI: 10.1007/s40268-016-0144-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
58 Gellert P, Bethke N, Seybold J. School-based educational and on-site vaccination intervention among adolescents: study protocol of a cluster randomised controlled trial. BMJ Open 2019;9:e025113. [PMID: 30700487 DOI: 10.1136/bmjopen-2018-025113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Lahariya C. Vaccine epidemiology: A review. J Family Med Prim Care 2016;5:7-15. [PMID: 27453836 DOI: 10.4103/2249-4863.184616] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
60 NNDSS Annual Report Working Group. Australia's notifiable disease status, 2016: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell (2018) 2021;45. [PMID: 34074234 DOI: 10.33321/cdi.2021.45.28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
61 Greydanus DE, Leonov A, Elisa A, Azmeh R. Should rare immunologic, neurologic, and other adverse events be indications to withhold vaccination? Transl Pediatr 2019;8:419-27. [PMID: 31993356 DOI: 10.21037/tp.2019.06.01] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]